semaglutide dopamine reddit Hedonic eating is controlled by neurons that oppose GLP-1R satiety A new clinical trial supported
Description
Eligible trials compared any of the specified doses of tirzepatide and semaglutide against each other, placebo or other glucose-lowering drugs
Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) drug use appears to be associated with increased residual gastric content (RGC) detected by gastric ultrasonography, a major risk factor for aspiration
Summary In summary, GLP-1 RA based therapies are being rigorously studied in management of MASLD in particular more advanced stages and likely will become foundational therapies in the future.
Retatrutide hit 28.3% weight loss in the May 2026 trial
Every claim is backed by citations from PubMed-indexed medical journals
